Loic Ysebaert

21PUBLICATIONS
156CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Models of care and place of birthTumour immunologyHaematological tumoursEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Sep 30, 2026
A phase 1, first-in-human study of safimaltib, a MALT1 inhibitor, in B-lymphocytic malignancies.

|Sep 21, 2026
Contemporary Treatment and Survival Outcomes in Mantle Cell Lymphoma: A National Real-World Analysis From REALYSA, a LYSA Cohort.

|Sep 02, 2026
3D ex vivo platform for high-throughput immunotherapy screening in relapsed/refractory lymphoma patients.

|Jun 23, 2026
Comparative atrial fibrillation risk across Bruton's tyrosine kinase inhibitors in B-cell malignancies: A nationwide population-based study.

|Apr 26, 2025
Atezolizumab, obinutuzumab and venetoclax for the treatment of patients with relapsed/refractory B non-Hodgkin lymphoma: Final analysis of a phase II trial from the LYSA group.

Charles Herbaux, Emmanuel Bachy, Reda Bouabdallah

|Jan 22, 2025
Detection of clinically relevant variants in the TP53 gene below 10% allelic frequency: A multicenter study by ERIC, the European Research Initiative on CLL.

Sarka Pavlova, Jitka Malcikova, Lenka Radova

Pageof 4

Frequent Collaborators

4 joint publications

Franck Morschhauser

4 joint publications

Emmanuel Bachy

3 joint publications

Stéphanie Guidez

3 joint publications

René-Olivier Casasnovas